ENDLOS-TURBO PUT - BIOGEN IDEC | Delayed Deutsche Boerse AG 15:04:22 17/06/2024 BST | ||
| 7.29 EUR | +5.04% |
|
| Current month | -7.96% | ||
| 1 month | -6.22% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 17/06/24 | 7.29 | +5.04% |
| 14/06/24 | 6.94 | +2.66% |
| 13/06/24 | 6.76 | -5.06% |
| 12/06/24 | 7.12 | -3.78% |
| 11/06/24 | 7.4 | -0.40% |
Delayed Quote Deutsche Boerse AG
Last update June 17, 2024 at 03:04 pm
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ2XM7 |
| ISIN | DE000DJ2XM70 |
| Date issued | 05/10/2023 |
| Strike | 303.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.792 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.9 € |
|---|---|
| Lowest since issue | 3.33 € |
| Spread | 0.01 € |
| Spread % | 0.14% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
231.7
USD
Average target price
284.6
USD
Spread / Average Target
+22.85%
- Stock Market
- Certificates
- Certificat